Amundi Stoxx Europe Select Dividend 30 UCITS ETF Dist (SELP)

Wait, did I miss something?

That also raises the future filing issue. A peer reviewed PSM paper may help a future FDA BLA, but it would not make an MHRA rejection disappear. FDA’s first question would still be: why did MHRA say no after more than 2.5 years?

As I stated

Up 19* today with 122k at ask of 83* and 27k more in the afternoon …

SSKMP Managed Index (As Of 7/8/26)

Daily Performance
-0.68%

YTD Performance
+5.79%

Overall Performance
+525.53% (Including Options Trading +389.51%)

imanjen13,  The news regarding Alkermes and Amneal is about generic Vivitrol, Naltrexone suspension for injection.  Elite makes Naltrexone tablets.  Unfortunately this news has nothing to do with Elite.

>>> Katie Couric reveals diagnosis of temporary memory-robbing condition


NBC News

by David K. Li

7-8-26


https://www.msn.com/en-us/health/other/katie-couric-reveals-diagnosis-of-temporary-memory-robbing-condition/ar-AA27tJZr?

The 3 points takeaways from this SEC filing.
1. Greater transparency. By filing an 8-K, TWOH is informing all shareholders of a material event through an official SEC filing rather than relying solely on a press release. That can improve investor confidence.
2. A significant corporate

I said they should, instead of them trying to use some evasive language, but you changed that to me stating they would, and had an argument against yourself.

You do this constantly to people.

Thanks Paullee for the transsion information. Hopefully, IDCC will announce a settlement with transsion next.

The company has gone from ~135 million shares in 2015 to over 550 million shares today. That’s more than 4x dilution in about 10 years, all while generating zero revenue from their product.
And it’s about to get worse.
With only ~199 million authorized shares remaining, they are likely

well if Linda said it then it must be true. Because she has historically delivered on previous forward looking statements



end sarcasm

I was worried but I’m not giving up hope. 

Although for NWBO, 4-5 PR's within the 6 months following approval would feel like a Biblical level flood of information.
On occasion, you do make me laugh.

Nasdaq.com's Revenue/EPS page is now gone apparently. My old link doesn't work, and I don't see the link where it used to be on the page. Maybe it's behind a pay wall now. I don't know.

I was able to find a workaround, though. Here is a link to the Spanish language version:

What did I misunderstand Flip?

You said that NWBO should announce a partnership at the same time as approval.

I said that is too optimistic, even if a handshake deal is in place, it won't get done like that.

You disagreed.

So what am I misu

10Y/USD spiked, BUT both sold today & look topped short term imo, another clue this may be a false market breakdown:

https://schrts.co/IsvNMTIP

ITS NOW OR NEVER NUCLEAR SHORT SQUEEZE OR THE BIGGEST SCAM IN STOCK MARKET HISTORY

The potential is there

Amazing! We are obviously on the cusp of major medical breakthroughs and I have no doubt that RespireRX will be included.

Again, your reading comprehension is abysmal. You change what people say, than argue against that.

$BATL US bombing Iran for 2nd straight day after Trump declares cease-fire with ‘sick’ regime ‘over’
https://nypost.com/2026/07/08/us-news/us-bombing-iran-for-2nd-straight-day-after-trump-declares-cease-fire-over-for-sick-regime/

This is good for BATL pps going up here!

https://investorshub.advfn.com/uimage/uploads/2026/7/8/ghzpemillennials_GUTSI_crypto_investing.jpg

He gets spanked again.

https://media1.giphy.com/media/v1.Y2lkPTc5MGI3NjExM3MzaTZxenRxMTk5cnNneG02OGRjMWZ0cDV2Z2Z0ZmIyMWt0OHBjeSZlcD12MV9naWZzX3NlYXJjaCZjdD1n/pRotk2UQTsozm/200.webp

$BATL US bombing Iran for 2nd straight day after Trump declares cease-fire with ‘sick’ regime ‘over’
https://nypost.com/2026/07/08/us-news/us-bombing-iran-for-2nd-straight-day-after-trump-declares-cease-fire-over-for-sick-regime/

This is good for BATL pps going up here!

Oh boy

Okay Flip.

Keep the pump strong. Can't wait to hear your excuses when a partnership isn't announced at the same time as approval.